🏛️ Verified NIH Record • Updated 2026-07-09
Clinical Trial Multi-analyte Blood Test (NCT03694600)
Prospective Clinical Trial to Detect Liver Cancer Through Quantification of cfDNA Methylation in Blood Samples: A LAM Insight Trial Study
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Helio Genomics
🩺 Plain-English Summary (8th-Grade Level)
This is a clinical trial designed to evaluate the performance of a multi-analyte blood test alone to ultrasound alone for the detection of HCC within a population that is at high risk for HCC due to liver cirrhosis.
Who can join: Review the eligibility criteria below.
Location: AZ Liver Health (Chandler) — Chandler, Arizona
Age range: 21 Years to 84 Years
🧪 Interventions in This Study
- Multi-analyte blood Test (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (38 Sites)
Showing the first 25 of 38 sites.
- AZ Liver Health (Chandler) — Chandler, Arizona
- AZ Liver Health (Glendale, Peoria) — Peoria, Arizona
- AZ Liver Health (Tucson) — Tucson, Arizona
- Banner University Hospital (University of Arizona Tucson) — Tucson, Arizona
- Alliance Research Centers — Irvine, California
- University of South California — Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Stanford University — Palo Alto, California
- University of Colorado Hospital - Anschutz Cancer Pavilion — Aurora, Colorado
- Covenant Metabolic LLC — Fort Myers, Florida
- University of Florida Clinical and Translational Science Institute — Gainesville, Florida
- University of Miami - Schiff Center for Liver Diseases — Miami, Florida
- Gastroenterology Group of Naples — Naples, Florida
- Covenant Metabolics LLC — Sarasota, Florida
- Atlanta Gastroenterology — Atlanta, Georgia
- Piedmont Research Institute — Atlanta, Georgia
- Loyola University Medical Center — Maywood, Illinois
- St Luke's Hospital of Kansas City — Kansas City, Kansas
- University of Louisville — Louisville, Kentucky
- Tulane University Health Sciences Center — New Orleans, Louisiana
- Ochsner Clinic Foundation — New Orleans, Louisiana
- Louisiana Research Center, LLC — Shreveport, Louisiana
- Kansas City Research Institute (KCRI) — Kansas City, Missouri
- PMG Research of Winston-Salem — Winston-Salem, North Carolina
- University of Cincinnati College of Medicine — Cincinnati, Ohio
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Cirrhosis
- A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) — Chandler, Arizona
- Multi-analyte Blood Test Clinical Trial — Escondido, California
- Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis — Charlestown, Massachusetts
Explore by condition: All Liver Cirrhosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.